Life- threatening bleeding, pregnancy and lupus anticoagulant: Success after steroid and anticoagulant therapy

American Journal of Reproductive Immunology

Volumn 52, Issue 2, 2004, Pages 129-132

  Alijotas Reig, Jaume ^a,b,d   Ferrer Raventos, Juan Carlos ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Gynaicos Obstetric Clinic   (Spain)

^d NONE   (Spain)

Author keywords

Life threatening bleeding; Lupus anticoagulant; Pregnancy; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; ENOXAPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; MITOCHONDRION ANTIBODY; PREDNISONE; PROTHROMBIN; REAGINIC ANTIBODY; STEROID;

ABORTION; ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLEEDING; BLOOD CLOTTING TEST; CASE REPORT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTHROMBIN TIME; PUERPERIUM; REAGIN TEST; TREATMENT OUTCOME;

EID: 4344659449     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2004.00197.x     Document Type: Article

References (15)

1. Ordi J, Vilardell M, Oristrell J, Valdes M, Knobel A, Alijotas J, Monasterio Y, Flores P: Bleeding in patients with lupus anticoagulant. Lancet 1984; II:868-869.
2. Erkan D, Bateman H, Lockshin MD: Lupus anticoagulant-hipoprothrombinemia syndrome associated with systemic lupus erythematosus: report of two cases and review of literature. Lupus 1999; 8:560-564.
3. Stormorken H, Gjemdal T, Bjoro K: Lupus anticoagulant: a unique case with lupus anticoagulant and habitual abortion together with antifactor II antibody and bleeding tendency. Gynecol Obstet Invest 1988; 26:83-88.
4. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glicoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120-4124.
5. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda PJ, Barbuit T, Zwaad RFA, Bevers EM: Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335:1544-1547.
6. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RF: Lupus anticoagulant IgGs are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Throm Haemost 1991; 66:629-632.
7. von Landenberg P, Matthias T, Zaech J, Schultz M, Lorber M, Blank M, Shoenfeld Y: Antiprothrombin antibodies are associated with pregnancy loss in the patients with the antiphospholipid syndrome. Am J Reprod Immunol 2003; 49:51-56.
8. Erkan D, Yazici Y, Lockshin MD: Lupus anticoagulant-hypoprotrombinemia syndrome and pregnancy. Lupus 2001: 10:311-312.
9. Inbal A, Muszbek L: Coagulation factor deficiencies and pregnancy loss. Semin Thromb Haemost 2003; 29:171-174.
10. Wilson AW, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JCH, Brey R, Derksen R, Harris EN, Hughes GRV, Triplett DA, Khamasha MA: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42:1309-1311.
11. Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174:1584-1589.
12. Kutteh WH, Ermel LD: A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996; 35:402-407.
13. Kutteh WH, Yetman DL, Chantilis SJ, Crain J: Effect of antiphopholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Human Reprod 1997; 12:1171-1175.
14. Rai R, Cohen H, Dave M, Regan L: Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with antiphospholipid antibodies. BMJ 1997; 314:253-257.
15. Bick RL: Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: prevalence, treatment and outcome results. DRW Metroplex recurrent miscarriage syndrome cooperative group. Clin Appl Thromb Hemost 2000; 6:115-125.